These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22675428)

  • 1. A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV).
    Kim Y; Vaughan K; Greenbaum J; Peters B; Law M; Sette A
    PLoS One; 2012; 7(5):e38028. PubMed ID: 22675428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
    Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
    J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells.
    Ziegler S; Skibbe K; Walker A; Ke X; Heinemann FM; Heinold A; Mok JY; van Esch WJ; Yang D; Wölfl M; Timm J
    J Virol; 2014 Oct; 88(19):11080-90. PubMed ID: 25008925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
    Harcourt GC; Lucas M; Sheridan I; Barnes E; Phillips R; Klenerman P
    J Viral Hepat; 2004 Jul; 11(4):324-31. PubMed ID: 15230855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.
    von Delft A; Humphreys IS; Brown A; Pfafferott K; Lucas M; Klenerman P; Lauer GM; Cox AL; Gaudieri S; Barnes E
    Gut; 2016 Jan; 65(1):112-23. PubMed ID: 26092843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees.
    Shata MT; Anthony DD; Carlson NL; Andrus L; Brotman B; Tricoche N; McCormack P; Prince A
    J Viral Hepat; 2002 Nov; 9(6):400-10. PubMed ID: 12431201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of T-cell epitopes of hepatitis C virus genotype 5a.
    Gededzha MP; Mphahlele MJ; Selabe SG
    Virol J; 2014 Nov; 11():187. PubMed ID: 25380768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes.
    Kelly C; Swadling L; Brown A; Capone S; Folgori A; Salio M; Klenerman P; Barnes E
    Eur J Immunol; 2015 Jan; 45(1):309-16. PubMed ID: 25263407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design.
    Quadeer AA; Louie RH; Shekhar K; Chakraborty AK; Hsing IM; McKay MR
    J Virol; 2014 Jul; 88(13):7628-44. PubMed ID: 24760894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
    Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
    Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
    Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and characterization of an HCV-derived multi-epitope peptide antigen containing B-cell HVR1 mimotopes and T-cell conserved epitopes.
    Gao J; Gong Y; Zhao P; Zhu Q; Yang X; Qi Z
    Sci China C Life Sci; 2006 Oct; 49(5):490-9. PubMed ID: 17172057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoreactivity studies on synthetic peptides deriving from immunodominant region of hepatitis C virus NS5a gene].
    Shi LL; Dou XG; Feng GH; Fields H; Khudyakov Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):344-7. PubMed ID: 15650785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome: an accelerated approach toward epitope-driven vaccine development.
    Abdel-Hady KM; Gutierrez AH; Terry F; Desrosiers J; De Groot AS; Azzazy HM
    Hum Vaccin Immunother; 2014; 10(8):2366-77. PubMed ID: 25424944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERAP1 allotypes shape the epitope repertoire of virus-specific CD8
    Kemming J; Reeves E; Nitschke K; Widmeier V; Emmerich F; Hermle T; Gostick E; Walker A; Timm J; Price DA; Hofmann M; Thimme R; James E; Neumann-Haefelin C
    J Hepatol; 2019 Jun; 70(6):1072-1081. PubMed ID: 30769005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of CD4
    Lucas M; Deshpande P; James I; Rauch A; Pfafferott K; Gaylard E; Merani S; Plauzolles A; Lucas A; McDonnell W; Kalams S; Pilkinton M; Chastain C; Barnett L; Prosser A; Mallal S; Fitzmaurice K; Drummer H; Ansari MA; Pedergnana V; Barnes E; John M; Kelleher D; Klenerman P; Gaudieri S
    Sci Rep; 2018 May; 8(1):7224. PubMed ID: 29740042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of variation and selection in the HCV genome.
    Patiño-Galindo JÁ; González-Candelas F
    Infect Genet Evol; 2017 Apr; 49():104-110. PubMed ID: 28087495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
    Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8 epitope escape and reversion in acute HCV infection.
    Timm J; Lauer GM; Kavanagh DG; Sheridan I; Kim AY; Lucas M; Pillay T; Ouchi K; Reyor LL; Schulze zur Wiesch J; Gandhi RT; Chung RT; Bhardwaj N; Klenerman P; Walker BD; Allen TM
    J Exp Med; 2004 Dec; 200(12):1593-604. PubMed ID: 15611288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of conserved epitopes from hepatitis C virus for pan-populational stimulation of T-cell responses.
    Molero-Abraham M; Lafuente EM; Flower DR; Reche PA
    Clin Dev Immunol; 2013; 2013():601943. PubMed ID: 24348677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.